BrainLAB releases IGS product
BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems based in Westchester, IL, announced June 2 a patient positioning technology to support radiosurgery for high-risk spinal tumors. The patient positioning system is
BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems based in Westchester, IL, announced June 2 a patient positioning technology to support radiosurgery for high-risk spinal tumors. The patient positioning system is integrated into the Novalis Shaped Beam Surgery system. The BrainLAB technology confirms the location of the tumor prior to radiosurgery by comparing real-time images with a 3D model of the patient's anatomy created from images taken previously. Using the spine as a reference, the system precisely positions the patient's body for radiosurgery by repositioning the patient couch. The first clinical study, led by the Henry Ford Hospital radiosurgery team, demonstrated high precision and clinical effectiveness of extracranial radiosurgery in patients with spinal tumors.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
